Research

Energy balance

Fewer serious adverse events were reported with semaglutide compared to placebo.

Semaglutide may be a safer option for patients compared to placebo.

StrongSupportsmedium confidence
Fewer serious adverse events were reported with semaglutide vs placebo.
Subodh Verma et al. · Journal of the American College of Cardiology · 2024

Why this rating

Based on the large randomized controlled trial design.

Source

Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction

Subodh Verma et al. · Journal of the American College of Cardiology · 2024

DOI 10.1016/j.jacc.2024.06.001

rct · n=1145Cited 47×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →